Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Targeted co-delivery of curcumin and erlotinib by MoS2 nanosheets for the combination of synergetic chemotherapy and photothermal therapy of lung cancer

Fig. 2

TEM (a) and AFM (b) images of MoS2 and MoS2-PEG-Biotin. c Stability of MoS2 and MoS2-PEG-Biotin in water, PBS, and cell medium within 7 days. d Hemolysis percentages of red blood cell survival by MoS2-PEG-Biotin. Inset: images of the direct observation of hemolysis. Relative cell viability of HELF (e) and A549 (f) cells incubated with various concentrations of MoS2-PEG-Biotin for 24, 48, and 72 h

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us